Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4945112011 | Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4945113018 | Acetylcysteine 150 mg and taurine 500 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Mucolytic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Taurine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Taurine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Acetylcysteine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Acetylcysteine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only acetylcysteine and taurine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR